PHIO

PHIO PHARMACEUTICALS CORP

PHIO·71880W501·US·Common Stock·Healthcare - Biotechnology-13D/G

PHIO (PHIO PHARMACEUTICALS CORP) is held by 18 institutional investors as of Q2 2026. Largest holders: JANE STREET GROUP, LLC ($120,699), GEODE CAPITAL MANAGEMENT, LLC ($117,437), VANGUARD CAPITAL MANAGEMENT LLC ($96,619). Net institutional sentiment: Mixed.

18
Holders
(1 Elite)
$627,573
Total Value
54% (13)
Consensus
7 buying - 6 selling
13F: Insider & Congress: Updated regularly
PHIO

Smart Money Verdict

View all
Loading verdict
Held by 18 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 20, 2026 · Activists Feb 17, 2026 · Congress none

InsiderPTPlott Ronald ToddBuy $17KAug 19, 2026
InsiderBJBitterman Robert JBuy $11KAug 18, 2026
InsiderBJBitterman Robert JBuy $10KJun 26, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
117,755(-1.2%)$120,6990.0%+18.81%
0
Decreased
114,574(-22.2%)$117,4370.0%-1.66%
0
Increased
94,262(+18.0%)$96,6190.0%+18.54%
17
New
50,000$51,0000.0%+17.07%
28
Increased
47,500(+5.6%)$48,6880.0%-12.64%
15
New
47,150$48,3290.0%+17.07%
31
Unchanged
38,169$39,1230.0%+18.81%
0
Increased
27,768(+16.9%)$28,4620.0%+17.57%
15
Decreased
21,501(-33.8%)$22,0390.0%+18.28%
0
Decreased
18,475(-25.7%)$18,9370.0%+18.81%
0
Increased
11,605(+1032.2%)$11,8950.0%+17.22%
19
Unchanged
10,000$10,2500.0%+17.65%
0
Unchanged
6,000$6,1500.0%-36.54%
0
Decreased
5,387(-80.0%)$5,5220.0%+18.37%
0
Unchanged
2,000$2,0600.0%+18.81%
0
New
231$2370.0%+17.07%
17
Unchanged
110$1130.0%-6.98%
0
Decreased
13,182(-62.0%)$130.0%+18.81%
0
PHIOPHIOPHIO PHARMACEUTICALS CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used